Investing Ideas
/
Norwegian Pharmaceuticals & Biotech Financially Fit Penny Stocks

Norwegian Pharmaceuticals & Biotech Financially Fit Penny Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses

5 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
ABS Arctic Bioscience	NOK 1.83	-4.2%	-82.6%	NOK 46.4m	n/a	PS1.5x	E-12.8%	n/a
NYKD Nykode Therapeutics	NOK 3.05	0.9%	-85.8%	NOK 994.7m	NOK 11.50	PS20x	E-10.0%	n/a
PCIB PCI Biotech Holding	NOK 1.19	-8.8%	-43.3%	NOK 44.3m	n/a	PS7.4x	n/a	n/a
TRMED Thor Medical	NOK 2.63	-1.1%	103.9%	NOK 617.7m	n/a	PB2.4x	n/a	n/a
EXTX EXACT Therapeutics	NOK 3.76	-0.5%	-68.7%	NOK 120.6m	n/a	PB6.9x	n/a	n/a

Page 1 of 1